Calpains: attractive targets for the development of synthetic inhibitors
- PMID: 20166953
- DOI: 10.2174/156802610790725489
Calpains: attractive targets for the development of synthetic inhibitors
Abstract
The physiological roles of calpains are discussed, as are the associated pathological disorders that result from their over-activation. We also present practical information for establishing functional inhibition assays and an overview of X-ray crystal structures of calpain-inhibitor complexes to aid inhibitor design. These structures reveal the expected extended beta-strand conformation for the inhibitor backbone, a geometry that has been engineered into inhibitors with the introduction of either an N-terminal heterocycle or a macrocycle that links the P(1) and P(3) residues. The structure and function of all the main classes of inhibitors are reviewed, with most examples being classified according to the nature of the C-terminal reactive warhead group that reacts with the active site cysteine of calpains. These inhibitor classes include epoxysuccinate derivatives, aldehydes, aldehyde prodrugs (hemiacetals) and alpha-keto carbonyl compounds. Inhibitors derived from the endogenous inhibitor calpastatin and examples lacking a warhead, are now known and these are also discussed.
Similar articles
-
Rational Design of Calpain Inhibitors Based on Calpastatin Peptidomimetics.J Med Chem. 2016 Jun 9;59(11):5403-15. doi: 10.1021/acs.jmedchem.6b00267. Epub 2016 May 18. J Med Chem. 2016. PMID: 27148623
-
Structure-based design of allosteric calpain-1 inhibitors populating a novel bioactivity space.Eur J Med Chem. 2018 Sep 5;157:1264-1275. doi: 10.1016/j.ejmech.2018.08.049. Epub 2018 Aug 23. Eur J Med Chem. 2018. PMID: 30195237
-
Modulators of calpain activity: inhibitors and activators as potential drugs.Expert Opin Drug Discov. 2020 Apr;15(4):471-486. doi: 10.1080/17460441.2020.1722638. Epub 2020 Feb 5. Expert Opin Drug Discov. 2020. PMID: 32022614 Review.
-
A new cell-permeable calpain inhibitor.J Pept Sci. 2007 Jan;13(1):70-3. doi: 10.1002/psc.790. J Pept Sci. 2007. PMID: 17019744
-
Developments in the design and synthesis of calpain inhibitors.Curr Opin Drug Discov Devel. 2005 Nov;8(6):684-700. Curr Opin Drug Discov Devel. 2005. PMID: 16312145 Review.
Cited by
-
Attenuation of Blood-Brain Barrier Breakdown and Hyperpermeability by Calpain Inhibition.J Biol Chem. 2016 Dec 30;291(53):26958-26969. doi: 10.1074/jbc.M116.735365. Epub 2016 Nov 8. J Biol Chem. 2016. PMID: 27875293 Free PMC article.
-
IL-1α Gene Deletion Protects Oligodendrocytes after Spinal Cord Injury through Upregulation of the Survival Factor Tox3.J Neurosci. 2015 Jul 29;35(30):10715-30. doi: 10.1523/JNEUROSCI.0498-15.2015. J Neurosci. 2015. PMID: 26224856 Free PMC article.
-
Calpastatin prevents NF-κB-mediated hyperactivation of macrophages and attenuates colitis.J Immunol. 2013 Oct 1;191(7):3778-88. doi: 10.4049/jimmunol.1300972. Epub 2013 Aug 28. J Immunol. 2013. PMID: 23986533 Free PMC article.
-
Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors.Acta Pharm Sin B. 2015 Nov;5(6):506-19. doi: 10.1016/j.apsb.2015.08.001. Epub 2015 Sep 26. Acta Pharm Sin B. 2015. PMID: 26713267 Free PMC article. Review.
-
The Complexity of Secondary Cascade Consequent to Traumatic Brain Injury: Pathobiology and Potential Treatments.Curr Neuropharmacol. 2021;19(11):1984-2011. doi: 10.2174/1570159X19666210215123914. Curr Neuropharmacol. 2021. PMID: 33588734 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources